Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?
Tools
Tools
ToolsKalra, PR, Moon, J and Coats, AJ (2002) Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? American Heart Journal, 85 (2-3). pp. 195-197. ISSN 1097-6744
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Faculty \ School: | |
| Depositing User: | EPrints Services |
| Date Deposited: | 25 Nov 2010 11:13 |
| Last Modified: | 28 Apr 2022 19:32 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/15443 |
| DOI: |
Actions (login required)
 |
View Item |